J. Matthew Singleton, Director: Viking Therapeutics VKTX Sell · Filed 24/08/22

Trade details

Type: Insider sale
Amount: $397,404
Shares · price: 5,700 sh · $69.72 a share
Held after: 9,500 sh
Stock: Viking Therapeutics VKTX
Person: J. Matthew SingletonDirector
Trade date: 24/08/21
Filed: 24/08/22
Days to filing: 1 days

Sold 37.5% of holdings

Share of holding sold: 37.5%

Viking Therapeutics trades, last 26 weeks

What else happened in Viking Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

J. Matthew Singleton's recent trades

J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$1.3M
16,000 sh
$1.3M
Filed 24/10/25
Traded 24/10/25
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$715.9K
10,300 sh
$715.9K
Filed 24/09/20
Traded 24/09/20
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$278.9K
4,509 sh
$278.9K
Filed 24/08/19
Traded 24/08/19
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$186.3K
3,047 sh
$186.3K
Filed 24/08/19
Traded 24/08/19
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$153.1K
2,388 sh
$153.1K
Filed 24/08/19
Traded 24/08/19